Significantly, higher PTN expression informed poorer progression-free survival and overall survival in GBM patients (Fig. 1k,l), suggesting a potential pro-tumorigenic effect of PTN in promoting GBM malignancy. This evidence concerns the gene PTN and glioblastoma.